Telkonet, a small Milwaukee-area energy management and connected devices company, said this week it had hired the investment bank Roth Capital Partners “to explore strategic alternatives” with the goal of maximizing shareholder value.
Jason Tienor, president and CEO of Telkonet (OTCMKTS:... Read more »
More than a year after the FDA rejected Amgen’s experimental osteoporosis drug due to safety concerns, the Thousand Oaks, CA, company has teed up a new application.
The Amgen (NASDAQ: AMGN) drug, romosozumab (Evenity), is an antibody treatment meant... Read more »
Humans have had a drastic physical evolution recently—one that has notably taken only a few years. While the evolution from hunched primates to homo sapiens took tens of millions of years, we needed only about a decade to develop an arched... Read more »
It’s time to catch up on Boston tech headlines. This week, we’re tracking acquisitions by Autodesk and DataRobot, a $100 million investment in upstart wireless Internet provider Starry, a new startup from Runkeeper co-founder Jason Jacobs, details about a stealthy autonomous... Read more »
Drug price changes typically happen either at the start of the calendar year or the beginning of the third quarter. Such changes are routine for many companies, but Pfizer took an unusual step this week by rolling back scheduled price increases... Read more »
Cobalt is one of the ingredients in a type of rare earth magnet that, along with other rare earth magnets like neodymium and dysprosium, can be found in electric motors, smartphone batteries, and other products that are popular among consumers and... Read more »
Semiconductor maker Broadcom, which ended its effort to buy competitor Qualcomm earlier this year, has a new target: New York-based business software maker CA Technologies.
The pair announced Wednesday that Broadcom (NASDAQ: AVGO), which moved its headquarters from Singapore... Read more »
Just weeks ago, the FDA approved the first ever medicine made from a derivative of marijuana, a drug from GW Pharmaceuticals for a rare form of epilepsy. Yet competition already looms from San Diego’s Zogenix, thanks to new data the Emeryville,... Read more »
In a sea of emerging tech venture funds, Glasswing Ventures is trying to stand out. The Boston firm announced today it has closed its debut investment fund at $112 million.
That’s bigger than the “micro-VC” funds of the past decade, but... Read more »